#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4621277	B	Inhibition of pseudotyped HIV/EBOV GP infected in human A549 cells assessed as reduction in virus entry measured after 48 hrs by luciferase reporter gene assay	Ebolavirus	26		cell-based format	Scientific Literature
2.	ALA4621278	B	Inhibition of pseudotyped HIV/EBOV GP infected in human A549 cells assessed as reduction in virus entry at 12.5 uM measured after 48 hrs by luciferase reporter gene assay relative to control	Ebolavirus	47		cell-based format	Scientific Literature
3.	ALA4621279	B	Inhibition of pseudotyped HIV/MARV GP infected in human A549 cells assessed as reduction in virus entry measured after 48 hrs by luciferase reporter gene assay	Marburgvirus	25		cell-based format	Scientific Literature
4.	ALA4621280	B	Inhibition of pseudotyped HIV/MARV GP infected in human A549 cells assessed as reduction in virus entry at 12.5 uM measured after 48 hrs by luciferase reporter gene assay relative to control	Marburgvirus	47		cell-based format	Scientific Literature
5.	ALA4621281	T	Selectivity index, ratio of CC50 for human A549 cells to EC50 for HIV/EBOV-GP infected in human A549 cells		26		cell-based format	Scientific Literature
6.	ALA4621282	T	Selectivity index, ratio of CC50 for human A549 cells to EC50 for HIV/MARV-GP infected in human A549 cells		26		cell-based format	Scientific Literature
7.	ALA4621283	F	Antiviral activity against Ebola virus 1976 Mayinga infected in human HeLa cells pretreated for 1 hr followed by virus infection measured after 24 hrs by Hoechst staining-based immunofluorescence assay	Zaire ebolavirus	12		organism-based format	Scientific Literature
8.	ALA4621285	F	Antiviral activity against Marburg virus Lake Victoria, 2005 Angola infected in human HeLa cells pretreated for 1 hr followed by virus infection measured after 24 hrs by Hoechst staining-based immunofluorescence assay	Lake Victoria marburgvirus	12		organism-based format	Scientific Literature
9.	ALA4621286	T	Selectivity index, ratio of CC50 for human HeLa cells to EC50 for Ebola virus 1976 Mayinga in human HeLa cells		11		cell-based format	Scientific Literature
10.	ALA4621287	B	Inhibition of HIV/EBOV GP Y517S mutant infected in 293T cells assessed as reduction in virus entry	Ebolavirus	3		cell-based format	Scientific Literature
11.	ALA4621288	B	Inhibition of HIV/EBOV GP T519V mutant infected in 293T cells assessed as reduction in virus entry	Ebolavirus	2		cell-based format	Scientific Literature
12.	ALA4621289	A	Metabolic stability in human pooled plasma assessed as parent compound remaining at 20 uM after 60 mins by HPLC analysis	Homo sapiens	11		cell-free format	Scientific Literature
13.	ALA4621290	A	Metabolic stability in Sprague-Dawley rat pooled plasma assessed as parent compound remaining at 20 uM after 60 mins by HPLC analysis	Rattus norvegicus	11		cell-free format	Scientific Literature
14.	ALA4621291	A	Metabolic stability in human liver microsomes assessed as parent compound remaining after 60 mins in presence of NADPH by HPLC analysis	Homo sapiens	11		microsome format	Scientific Literature
15.	ALA4621292	A	Metabolic stability in Fischer F344 rat liver microsomes assessed as parent compound remaining after 60 mins in presence of NADPH by HPLC analysis	Rattus norvegicus	11		microsome format	Scientific Literature
16.	ALA4621293	A	Inhibition of recombinant human CYP3A4 expressed in baculovirus infected insect cell microsomes using vivid DBOMF as substrate preincubated for 10 mins followed by substrate addition and measured after 25 mins in presence of NAD+ by fluorescence assay	Homo sapiens	9		microsome format	Scientific Literature
17.	ALA4621294	A	Inhibition of recombinant human CYP2C9 expressed in baculovirus infected insect cell microsomes using vivid BOMF as substrate preincubated for 10 mins followed by substrate addition and measured after 25 mins in presence of NAD+ by fluorescence assay	Homo sapiens	9		microsome format	Scientific Literature